GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inovio Pharmaceuticals Inc (NAS:INO) » Definitions » E10

Inovio Pharmaceuticals (Inovio Pharmaceuticals) E10 : $-13.85 (As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Inovio Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Inovio Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2024 was $-1.310. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-13.85 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was -5.90% per year. During the past 5 years, the average E10 Growth Rate was -5.80% per year. During the past 10 years, the average E10 Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Inovio Pharmaceuticals was 26.60% per year. The lowest was -10.40% per year. And the median was 9.20% per year.

As of today (2024-06-09), Inovio Pharmaceuticals's current stock price is $9.59. Inovio Pharmaceuticals's E10 for the quarter that ended in Mar. 2024 was $-13.85. Inovio Pharmaceuticals's Shiller PE Ratio of today is .


Inovio Pharmaceuticals E10 Historical Data

The historical data trend for Inovio Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inovio Pharmaceuticals E10 Chart

Inovio Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.07 -11.60 -13.48 -14.88 -13.78

Inovio Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.95 -14.89 -14.17 -13.78 -13.85

Competitive Comparison of Inovio Pharmaceuticals's E10

For the Biotechnology subindustry, Inovio Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inovio Pharmaceuticals's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inovio Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Inovio Pharmaceuticals's Shiller PE Ratio falls into.



Inovio Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Inovio Pharmaceuticals's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.31/131.7762*131.7762
=-1.310

Current CPI (Mar. 2024) = 131.7762.

Inovio Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201406 -2.280 100.560 -2.988
201409 -1.440 100.428 -1.889
201412 -1.440 99.070 -1.915
201503 -2.160 99.621 -2.857
201506 -1.080 100.684 -1.414
201509 0.840 100.392 1.103
201512 -3.120 99.792 -4.120
201603 -1.320 100.470 -1.731
201606 -3.120 101.688 -4.043
201609 -3.360 101.861 -4.347
201612 -4.320 101.863 -5.589
201703 -3.720 102.862 -4.766
201706 -1.560 103.349 -1.989
201709 -4.800 104.136 -6.074
201712 -2.880 104.011 -3.649
201803 -4.320 105.290 -5.407
201806 -0.960 106.317 -1.190
201809 -3.240 106.507 -4.009
201812 -4.200 105.998 -5.221
201903 -3.600 107.251 -4.423
201906 -3.600 108.070 -4.390
201909 -3.000 108.329 -3.649
201912 -4.560 108.420 -5.542
202003 -3.120 108.902 -3.775
202006 -9.960 108.767 -12.067
202009 1.320 109.815 1.584
202012 -1.320 109.897 -1.583
202103 -3.240 111.754 -3.820
202106 -4.680 114.631 -5.380
202109 -3.480 115.734 -3.962
202112 -6.050 117.630 -6.778
202203 -4.320 121.301 -4.693
202206 -5.520 125.017 -5.818
202209 -1.800 125.227 -1.894
202212 -2.550 125.222 -2.683
202303 -1.890 127.348 -1.956
202306 -1.560 128.729 -1.597
202309 -1.560 129.860 -1.583
202312 -1.050 129.419 -1.069
202403 -1.310 131.776 -1.310

Add all the adjusted EPS together and divide 10 will get our e10.


Inovio Pharmaceuticals  (NAS:INO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Inovio Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Inovio Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Inovio Pharmaceuticals (Inovio Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Executives
Lota S. Zoth director 334 CR 692, BUFFALO GAP TX 79508
David B. Weiner director 717 BEACOM LANE, MERION STATION PA 19066-1603
Simon X Benito director 967 LAWRENCE AVE, WESTFIELD NJ 07090
Michael John Sumner officer: Chief Medical Officer 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING PA 19462
Laurent Humeau officer: Chief Scientific Officer C/O INOVIO PHARMACEUTICALS, INC., 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING PA 19462
Jacqueline Elizabeth Shea officer: Chief Operating Officer C/O INOVIO PHARMACEUTICALS, INC., 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING PA 19462
Peter Kies officer: CFO
Roger D Dansey director 21823 30TH DRIVE SE, BOTHELL WA 98021
Jong Joseph Kim director, officer: Chief Executive Officer 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING PA 19462
Jay Shepard director 15977 GRANDVIEW AVENUE, MONTE SERENO CA 95030
Ann Calby Miller director C/O INOVIO PHARMACEUTICALS, INC., 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING PA 19462
Wendy L Yarno director
Morton Collins director
George Bickerstaff director C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Niranjan Sardesai officer: Chief Operating Officer VGX PHARMACEUTICALS, INC., 450 SENTRY PARKWAY, BLUE BELL PA 19422

Inovio Pharmaceuticals (Inovio Pharmaceuticals) Headlines